Società Concordia International Corp Nasdaq
Azioni
CA20653P1027
Prodotti farmaceutici
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Steffen Wagner
CEO | Chief Executive Officer | - | 01/04/22 |
Andreas Stickler
DFI | Director of Finance/CFO | 53 | 01/01/22 |
Nick Warwick
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/20 |
Karl Belk
COO | Chief Operating Officer | 56 | 01/10/15 |
Adam Peeler
IRC | Investor Relations Contact | - | 01/11/15 |
Corporate Officer/Principal | - | - | |
General Counsel | - | 01/05/22 | |
Fiona Huzarski
HRO | Human Resources Officer | - | - |
Simon Tucker
PRN | Corporate Officer/Principal | - | 01/06/18 |
Chris Britten
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Raj Shah
BRD | Director/Board Member | 55 | - |
Rainer Lenhard
BRD | Director/Board Member | - | - |
Steffen Wagner
CEO | Chief Executive Officer | - | 01/04/22 |
Andreas Stickler
DFI | Director of Finance/CFO | 53 | 01/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 48 913 490 | 48 854 243 ( 99,88 %) | 0 | 99,88 % |
Coordinate società
Advanz Pharma Corp. Ltd.
Capital House 85 King William Street
EC4N 7BL, London
+44 2085 889 100
http://www.advanzpharma.comSocietà del gruppo
Nome | Categoria e settore |
---|---|
Advanz Pharma (Jersey) Ltd.
Advanz Pharma (Jersey) Ltd. Pharmaceuticals: MajorHealth Technology Part of Advanz Pharma Corp. Ltd., Advanz Pharma (Jersey) Ltd. develops pharmaceutical products and medical devices. The company is based in St. Helier, UK. |
Pharmaceuticals: Major
|
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+40,73% | 739 Mrd | |
+32,83% | 598 Mrd | |
-6,30% | 353 Mrd | |
+15,15% | 318 Mrd | |
+4,05% | 285 Mrd | |
+15,00% | 240 Mrd | |
-5,52% | 206 Mrd | |
+6,17% | 164 Mrd | |
-0,45% | 162 Mrd |